![Effect of chronic candesartan (0.1 mg/kg/day, p.o., 21 days), chronic... | Download Scientific Diagram Effect of chronic candesartan (0.1 mg/kg/day, p.o., 21 days), chronic... | Download Scientific Diagram](https://www.researchgate.net/publication/230665981/figure/fig1/AS:300617273757696@1448684151146/Effect-of-chronic-candesartan-01-mg-kg-day-po-21-days-chronic-restraint-stress-2.png)
Effect of chronic candesartan (0.1 mg/kg/day, p.o., 21 days), chronic... | Download Scientific Diagram
![PDF) Long-Term Dual Blockade With Candesartan and Lisinopril in Hypertensive Patients With Diabetes The CALM II study PDF) Long-Term Dual Blockade With Candesartan and Lisinopril in Hypertensive Patients With Diabetes The CALM II study](https://i1.rgstatic.net/publication/8053886_Long-Term_Dual_Blockade_With_Candesartan_and_Lisinopril_in_Hypertensive_Patients_With_Diabetes_The_CALM_II_study/links/55e75fa708aeb6516262e14c/largepreview.png)
PDF) Long-Term Dual Blockade With Candesartan and Lisinopril in Hypertensive Patients With Diabetes The CALM II study
![Real world effectiveness and tolerability of candesartan in the treatment of migraine: a retrospective cohort study | Scientific Reports Real world effectiveness and tolerability of candesartan in the treatment of migraine: a retrospective cohort study | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-83508-2/MediaObjects/41598_2021_83508_Fig1_HTML.png)
Real world effectiveness and tolerability of candesartan in the treatment of migraine: a retrospective cohort study | Scientific Reports
![Candesartan Effectively Preserves Cognition in Senescence Accelerated Mouse Prone 8 (SAMP8) mice - IOS Press Candesartan Effectively Preserves Cognition in Senescence Accelerated Mouse Prone 8 (SAMP8) mice - IOS Press](https://content.iospress.com/media/adr/2022/6-1/adr-6-1-adr220016/adr-6-adr220016-g001.jpg)
Candesartan Effectively Preserves Cognition in Senescence Accelerated Mouse Prone 8 (SAMP8) mice - IOS Press
![Candesartan Effectively Preserves Cognition in Senescence Accelerated Mouse Prone 8 (SAMP8) mice - IOS Press Candesartan Effectively Preserves Cognition in Senescence Accelerated Mouse Prone 8 (SAMP8) mice - IOS Press](https://content.iospress.com/media/adr/2022/6-1/adr-6-1-adr220016/adr-6-adr220016-g004.jpg)
Candesartan Effectively Preserves Cognition in Senescence Accelerated Mouse Prone 8 (SAMP8) mice - IOS Press
![Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients: the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex) | Hypertension Research Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients: the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex) | Hypertension Research](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fhr.2011.120/MediaObjects/41440_2011_Article_BFhr2011120_Fig1_HTML.jpg)
Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients: the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex) | Hypertension Research
Effects of Candesartan on Electrical Remodeling in the Hearts of Inherited Dilated Cardiomyopathy Model Mice | PLOS ONE
![Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial - The Lancet Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial - The Lancet](https://www.thelancet.com/cms/attachment/2000986351/2003622559/gr1.jpg)
Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial - The Lancet
![JCM | Free Full-Text | The Treatment of Heart Failure in Patients with Chronic Kidney Disease: Doubts and New Developments from the Last ESC Guidelines JCM | Free Full-Text | The Treatment of Heart Failure in Patients with Chronic Kidney Disease: Doubts and New Developments from the Last ESC Guidelines](https://www.mdpi.com/jcm/jcm-11-02243/article_deploy/html/images/jcm-11-02243-g001-550.jpg)
JCM | Free Full-Text | The Treatment of Heart Failure in Patients with Chronic Kidney Disease: Doubts and New Developments from the Last ESC Guidelines
![Candesartan Cilexetil and Hydrochlorothiazide Tablets, 16 mg/12.5 mg, for oral use/Candesartan Cilexetil and Hydrochlorothiazide Tablets, 32 mg/12.5 mg, for oral use/Candesartan Cilexetil and Hydrochlorothiazide Tablets, 32 mg/25 mg, for oral use Candesartan Cilexetil and Hydrochlorothiazide Tablets, 16 mg/12.5 mg, for oral use/Candesartan Cilexetil and Hydrochlorothiazide Tablets, 32 mg/12.5 mg, for oral use/Candesartan Cilexetil and Hydrochlorothiazide Tablets, 32 mg/25 mg, for oral use](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=c1328cfd-figure-01.jpg&id=570036)
Candesartan Cilexetil and Hydrochlorothiazide Tablets, 16 mg/12.5 mg, for oral use/Candesartan Cilexetil and Hydrochlorothiazide Tablets, 32 mg/12.5 mg, for oral use/Candesartan Cilexetil and Hydrochlorothiazide Tablets, 32 mg/25 mg, for oral use
![Candesartan Cilexetil Hydrochlorothiazide Tablets (candesartan cilexetil hydrochlorothiazide): Uses, Dosage, Side Effects, Interactions, Warning Candesartan Cilexetil Hydrochlorothiazide Tablets (candesartan cilexetil hydrochlorothiazide): Uses, Dosage, Side Effects, Interactions, Warning](https://images.rxlist.com/images/rxlist/candesartan-cilexetil-hydrochlorothiazide-generic1.gif)
Candesartan Cilexetil Hydrochlorothiazide Tablets (candesartan cilexetil hydrochlorothiazide): Uses, Dosage, Side Effects, Interactions, Warning
![JCM | Free Full-Text | An Up-to-Date Article Regarding Particularities of Drug Treatment in Patients with Chronic Heart Failure JCM | Free Full-Text | An Up-to-Date Article Regarding Particularities of Drug Treatment in Patients with Chronic Heart Failure](https://pub.mdpi-res.com/jcm/jcm-11-02020/article_deploy/html/images/jcm-11-02020-g001.png?1649072177)